Chowdhury I H, Chao W, Potash M J, Sova P, Gendelman H E, Volsky D J
Molecular Virology Laboratory, St. Luke's/Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York 10019, USA.
J Virol. 1996 Aug;70(8):5336-45. doi: 10.1128/JVI.70.8.5336-5345.1996.
The vif gene of human immunodeficiency virus type 1 (HIV-1) is required for efficient infection of primary T lymphocytes. In this study, we investigated in detail the role of vif in productive infection of primary monocyte-derived macrophages (MDM). Viruses carrying missense or deletion mutations in vif were constructed on the background of the monocytotropic recombinant NLHXADA-GP. Using MDM from multiple donors, we found that vif mutants produced in complementing or partially complementing cell lines were approximately 10% as infectious as wild-type virus when assayed for incomplete, complete, and circularized viral DNA molecules by quantitative PCR amplification or for viral core antigen p24 production by enzyme-linked immunosorbent assay. We then determined the structure and infectivity of vif mutant HIV-1 by using MDM exclusively both for virus production and as targets for infection. Biosynthetic labeling and immunoprecipitation analysis of sucrose cushion-purified vif-negative HIV-1 made in MDM revealed that the virus had reduced p24 content compared with wild-type HIV-1. Cell-free MDM-derived vif mutant HIV-1 was infectious in macrophages as determined by the synthesis and maintenance of full-length viral DNA and by the produc- tion of particle-associated viral RNA, but its infectivity was approximately 2,500-fold lower than that of wild-type virus whose titer was determined in parallel by measurement of the viral DNA burden. MDM infected with MDM-derived vif-negative HIV-1 were able to transmit the virus to uninfected MDM by cocultivation, confirming the infectiousness of this virus. We conclude that mutations in vif significantly reduce but do not eliminate the capacity of HIV-1 to replicate and produce infectious progeny virus in primary human macrophages.
人类免疫缺陷病毒1型(HIV-1)的vif基因对于原代T淋巴细胞的有效感染是必需的。在本研究中,我们详细研究了vif在原代单核细胞衍生巨噬细胞(MDM)的 productive 感染中的作用。在嗜单核细胞重组NLHXADA-GP的背景上构建了在vif中携带错义或缺失突变的病毒。使用来自多个供体的MDM,当通过定量PCR扩增检测不完全、完全和环化的病毒DNA分子或通过酶联免疫吸附测定检测病毒核心抗原p24的产生时,我们发现,在互补或部分互补细胞系中产生的vif突变体的感染性约为野生型病毒的10%。然后,我们专门使用MDM进行病毒生产并作为感染靶标,确定了vif突变型HIV-1的结构和感染性。对MDM中产生的经蔗糖垫层纯化的vif阴性HIV-1进行生物合成标记和免疫沉淀分析,结果显示,与野生型HIV-1相比,该病毒的p24含量降低。通过全长病毒DNA的合成和维持以及颗粒相关病毒RNA的产生确定,MDM来源的无细胞vif突变型HIV-1在巨噬细胞中具有感染性,但其感染性比通过测量病毒DNA负荷并行确定滴度的野生型病毒低约2500倍。感染MDM来源的vif阴性HIV-1的MDM能够通过共培养将病毒传播给未感染的MDM,证实了该病毒的感染性。我们得出结论,vif中的突变显著降低但并未消除HIV-1在原代人巨噬细胞中复制和产生有感染性子代病毒的能力。